MedPath

Relieving the Bile Ducts Prior to Pancreatoduodenectomy

Completed
Conditions
Surgery-Complications
Biliary Fistula
Pancreas Cancer
Interventions
Procedure: Preoperative biliary drainage (ERC og PTC-aided)
Registration Number
NCT05434520
Lead Sponsor
Rigshospitalet, Denmark
Brief Summary

The aim of this study was to assess the risk and complications after preoperative drainage of biliary obstruction in patients who underwent pancreatoduodenectomy.

A retrospective cohort study of all patients who underwent pancreatoduodenectomy from January 1st, 2015 to September 30th, 2021. Patients who had preoperative bile duct drainage were compared to patients without intervention. Type of interventions, complications and outcome after surgery were compared using univariate and multivariate analysis.

Detailed Description

Obstructive jaundice is a common problem in pancreatic and periampullary tumors, but preoperative biliary drainage in patients with hyperbilirubinemia is still controversial. The aim of this retrospective cohort study was to assess the risk and complications after preoperative drainage of biliary obstruction in patients who underwent pancreatoduodenectomy.

A retrospective cohort study of all patients who underwent pancreatoduodenectomy from January 1st, 2015 to September 30th, 2021.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
722
Inclusion Criteria
  • All patients who had undergone pancreatoduodenectomy
Exclusion Criteria
  • None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Preoperative biliary drainagePreoperative biliary drainage (ERC og PTC-aided)Patients who had undergone preoperative biliary drainage (ERC og PTC) prior to pancreatoduodenectomy
Primary Outcome Measures
NameTimeMethod
90-day Mortalityup to 90 days

90-day mortality rate post-pancreatoduodenectomy

Length of Hospital StayDays from admission until discharge, up to 390 days, median time 13 days

Accumulated length of hospital stay from the admission day prior to pancreatoduodenectomy, till the day of discharge.

30-day Readmissionup to 30-days from hospital discharge

Prevalence of readmission within 30-days after discharge following pancreatoduodenectomy.

Post-operative complication score (Clavien-Dindo)During hospital admission, median time 13 days, up to 390 days.

The prevalence of complications graded according to Clavien-Dindo score after pancreatoduodenectomy. Clavien-Dindo 0 is no complications, Clavien-Dindo 5 means complications resulting in mortality.

30-day Mortalityup to 30 days

30-day mortality rate post-pancreatoduodenectomy

Secondary Outcome Measures
NameTimeMethod
Histological SpecimenObtained within 21 days after resection

Histological diagnosis of the resection specimens divided in malignant (ductal adenocarcinoma, cholangiocarcinoma, papillary carcinoma, duodenal adenocarcinoma, neuroendocrine tumor, other pancreatic carcinoma, other malignancy in the pancreas) and benign (IPMN, other benign diseases).

Complications following preoperative bile duct drainageup to 7 days after bile duct drainage

Prevalence of cholangitis, pancreatitis, iatrogenic perforation, post-procedural bleeding and post-procedural thrombosis

Time from Bile Duct Drainage to PancreatoduodenectomyDays from bile duct decompression to pancreatoduodenectomy, median time 32 days, up to 534 days

Time from Bile Duct Decompression to pancreatoduodenectomy.

Trial Locations

Locations (1)

Rigshospitalet

🇩🇰

Copenhagen, Capitol, Denmark

© Copyright 2025. All Rights Reserved by MedPath